De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients.
about
Antibody persistence 1 year after pandemic H1N1 2009 influenza vaccination and immunogenicity of subsequent seasonal influenza vaccine among adult organ transplant patients.Influenza vaccination in immunocompromised patients: efficacy and safety.Impact of squalene-based adjuvanted influenza vaccination on graft outcome in kidney transplant recipients.Effect of the adjuvanted (AS03) A/H1N1 2009 pandemic influenza vaccine on the risk of rejection in solid organ transplant recipients in England: a self-controlled case seriesAdjuvanted (AS03) A/H1N1 2009 Pandemic Influenza Vaccines and Solid Organ Transplant Rejection: Systematic Signal Evaluation and Lessons Learnt.The antibody response to pandemic H1N1 2009 influenza vaccine in adult organ transplant patients.Optimizing the immunogenicity of pandemic H1N1 2009 influenza vaccine in adult organ transplant patients.Antibody response to the non-adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipients.Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients.Immunogenicity of pandemic influenza A H1N1/2009 adjuvanted vaccine in pediatric solid organ transplant recipients.Behaviour of non-donor specific antibodies during rapid re-synthesis of donor specific HLA antibodies after antibody incompatible renal transplantation.HLA sensitisation: can it be prevented?Influenza virus vaccination and kidney graft rejection: causality or coincidenceUtility of HLA Antibody Testing in Kidney Transplantation.Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease.Impact of immunosuppression on recall immune responses to influenza vaccination in stable renal transplant recipientsImmunizations in solid organ and hematopoeitic stem cell transplant patients: A comprehensive review.Influenza vaccination in the organ transplant recipient: review and summary recommendations.TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition.Identification and therapeutic management of highly sensitized patients undergoing renal transplantation.Pneumococcal immunization in immunocompromised hosts: where do we stand?Washing red cells after leucodepletion does not decrease human leukocyte antigen sensitization risk in patients with chronic kidney disease.Changing face of vaccination in immunocompromised hosts.Immunization after kidney transplantation-what is necessary and what is safe?Clinical relevance of HLA antibody monitoring after kidney transplantation.Pediatric deceased donor renal transplantation: An approach to decision making II. Acceptability of a deceased donor kidney for a child, a snap decision at 3 AM.The risks of using allogeneic cell lines for vaccine production: the example of Bovine Neonatal Pancytopenia.Infectious pathogens may trigger specific allo-HLA reactivity via multiple mechanisms.Two Doses of Inactivated Influenza Vaccine Improve Immune Response in Solid Organ Transplant Recipients: Results of TRANSGRIPE 1-2, a Randomized Controlled Clinical Trial.Heterologous Immune Responses to Influenza Vaccine in Kidney Transplant Recipients.Influenza vaccination and humoral alloimmunity in solid organ transplant recipients.Immunogenicity of a prophylactic quadrivalent human papillomavirus L1 virus-like particle vaccine in male and female adolescent transplant recipients.HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages.Vaccination in solid organ transplantation.RNA respiratory viruses in solid organ transplantation.Males without apparent alloimmunization could have HLA antibodies that recognize target HLA specificities expressed on cells.Humoral immunomodulatory effect of influenza vaccine in potential blood donors: implications for transfusion safety.Randomized controlled trial of high-dose intradermal versus standard-dose intramuscular influenza vaccine in organ transplant recipients.Seasonal influenza vaccine in immunocompromised persons.
P2860
Q30356208-6C5D75AF-9FC5-4A75-B7C6-FA1E8191E644Q30358640-E0F90F7B-5AD2-4AB9-9784-0D9E47080897Q30372284-B8548FCB-6C3B-4F8D-AF26-17B216C97C08Q30383985-96550519-560E-4E6E-844A-98BE7097E598Q30401136-8F3AB5FE-1EC3-4216-884D-7019F91EB13FQ30409959-7EBC1081-9DFA-44B3-820B-D6D45F6F0A53Q30416238-C02BED36-E4F5-438F-97A6-33AD5DF0AF24Q30420230-321478BA-D4D2-4137-88F5-45F699E4880FQ30421507-9730908E-81D6-4AAA-A3C2-40EA71A1EDDCQ30430823-3E9502B3-1D8F-47F9-B36D-CD9573A73D6DQ34901704-68EFBF14-A51E-4DD3-819C-E2E2EBE1910EQ35097898-18E9DB6F-6527-4AB7-B084-61AAA3593A44Q35633460-166E623C-F49D-4FA3-8C6F-40ECEE58F2B5Q35790601-121FF9A3-6452-4F3E-AEB6-A725454AA7A3Q35811966-712E2742-72D7-41B6-90AC-6A01391DBBC0Q36832305-F52DED20-65C1-4370-AE4F-99B42FD005D2Q37320197-3A3542D8-08F0-4DAD-BAB3-91A4B092E1B6Q37940524-E38ED9A0-DC61-4CB0-BD0F-69F45A1EDFC3Q37965366-DE9389FB-31A7-4531-8F70-82CF5F5ADC7AQ38022711-E67A5E1C-3A16-4015-B736-428465EBADCCQ38168902-A4619CBD-670B-4E1E-9CF6-8ED76C8923F3Q38207911-C3999C7A-B365-48E5-A1F7-ECD56EA065B0Q38225998-2EDD568E-CD06-4A98-965A-429B4E488534Q38235003-3A78C4A1-0F8E-4D53-8A8D-17370EF425B7Q38265563-E2051DFB-417A-4332-9190-63D435042335Q38596671-C95778B1-01F9-4B26-942E-128F8BBD64A2Q38734701-55BED600-D063-4251-B111-E450FE144E63Q39440909-BA6D5A7F-4C70-448B-947D-94AC8CEB000EQ40270352-FF510F55-4F55-478E-9B97-691F3BB16DABQ40617701-5EA6AD06-B6CE-4898-A26C-FFF472AC622FQ42220410-C727341E-595C-49FE-A390-24D7669A8EF1Q42239771-FF91D1AF-39E5-475C-A42F-C1D075314ABBQ42270590-D2BCC584-82FA-46A9-925B-D5252DC6DD02Q42272271-095C79DF-3FC3-400D-8807-8D484EA33A46Q42272300-6F0041C2-066B-4AD7-A5E2-D637ADB64ADFQ47841676-3D3DD8E8-330C-490C-A0D2-6E41B6FB1CBAQ51419717-CB991756-81D5-46FF-B86D-DDE73D257EB9Q51831461-24EAAE98-F641-4FF1-B92D-2801F1F92C04Q54265837-AA4D1A70-A110-428A-A1A5-7F3F67BCD697
P2860
De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
De novo anti-HLA antibody afte ...... kidney transplant recipients.
@ast
De novo anti-HLA antibody afte ...... kidney transplant recipients.
@en
type
label
De novo anti-HLA antibody afte ...... kidney transplant recipients.
@ast
De novo anti-HLA antibody afte ...... kidney transplant recipients.
@en
prefLabel
De novo anti-HLA antibody afte ...... kidney transplant recipients.
@ast
De novo anti-HLA antibody afte ...... kidney transplant recipients.
@en
P2093
P2860
P921
P1476
De novo anti-HLA antibody afte ...... kidney transplant recipients.
@en
P2093
C van Delden
C-A Siegrist
I Katerinis
P-Y Martin
R Duquesnoy
S Ferrari-Lacraz
P2860
P304
P356
10.1111/J.1600-6143.2011.03604.X
P407
P577
2011-06-14T00:00:00Z